Bristol-Myers Squibb Company (BMY) financials · P/E 13, rev $48.19B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Bristol-Myers Squibb Company (BMY) P/E 13, rev $48.19B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $48.19B | $48.30B |
| Cost of Revenue | $13.94B | $13.97B |
| Gross Profit | $34.26B | $34.33B |
| Net Income | $7.05B | -$8.95B |
| EPS (Diluted) | $3.46 | -$4.41 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $90.04B | $92.60B |
| Current Assets | $29.39B | $29.78B |
| Cash & Equivalents | $10.21B | $10.35B |
| Inventory | $2.69B | $2.56B |
| PP&E | $7.54B | $7.14B |
| Total Liabilities | $71.53B | $76.22B |
| Current Liabilities | $23.42B | $23.77B |
| Short-term Debt | $2.26B | $2.05B |
| Long-term Debt | $42.85B | $47.60B |
| Total Debt | $45.11B† | $49.65B† |
| Shareholders' Equity | $18.47B | $16.34B |
| Retained Earnings | $16.90B | $14.91B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $14.16B | $15.19B |
| CapEx | $1.31B | $1.25B |
| Investing Cash Flow | -$4.13B | -$21.35B |
| Financing Cash Flow | -$10.35B | $5.13B |
| Dividends Paid | $5.04B | $4.86B |
| Net Change in Cash | -$129.0M | -$1.17B |
| Free Cash Flow | $12.85B | $13.94B |
FAQ
What is BMY P/E and revenue?
Bristol-Myers Squibb Company (BMY) P/E 13, rev $48.19B.
What is BMY revenue?
Bristol-Myers Squibb Company last cached revenue is $48.19B (FY2025).
Is BMY profitable?
Bristol-Myers Squibb Company last cached net income is $7.05B (FY2025).
What are BMY total assets?
Bristol-Myers Squibb Company last cached total assets are $90.04B (FY2025).
What is BMY free cash flow?
Bristol-Myers Squibb Company last cached free cash flow is $12.85B (FY2025).
Not investment advice. Cached statements, not a live tape.